These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7877143)

  • 21. A TIBO derivative, R82913, is a potent inhibitor of HIV-1 reverse transcriptase with heteropolymer templates.
    White EL; Buckheit RW; Ross LJ; Germany JM; Andries K; Pauwels R; Janssen PA; Shannon WM; Chirigos MA
    Antiviral Res; 1991 Oct; 16(3):257-66. PubMed ID: 1725247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human immunodeficiency virus 1 (HIV-1)-specific reverse transcriptase (RT) inhibitors may suppress the replication of specific drug-resistant (E138K)RT HIV-1 mutants or select for highly resistant (Y181C-->C181I)RT HIV-1 mutants.
    Balzarini J; Karlsson A; Sardana VV; Emini EA; Camarasa MJ; De Clercq E
    Proc Natl Acad Sci U S A; 1994 Jul; 91(14):6599-603. PubMed ID: 7517553
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel series of TSAO-T derivatives. Synthesis and anti-HIV-1 activity of 4-, 5-, and 6-substituted pyrimidine analogues.
    San-Félix A; Velázquez S; Pérez-Pérez MJ; Balzarini J; De Clercq E; Camarasa MJ
    J Med Chem; 1994 Feb; 37(4):453-60. PubMed ID: 7509877
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potent and highly selective human immunodeficiency virus type 1 (HIV-1) inhibition by a series of alpha-anilinophenylacetamide derivatives targeted at HIV-1 reverse transcriptase.
    Pauwels R; Andries K; Debyser Z; Van Daele P; Schols D; Stoffels P; De Vreese K; Woestenborghs R; Vandamme AM; Janssen CG
    Proc Natl Acad Sci U S A; 1993 Mar; 90(5):1711-5. PubMed ID: 7680476
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis of 2-(aminocarbonylmethylthio)-1H-imidazoles as novel Capravirine analogues.
    Loksha YM; el-Barbary AA; el-Badawi MA; Nielsen C; Pedersen EB
    Bioorg Med Chem; 2005 Jul; 13(13):4209-20. PubMed ID: 15896963
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Support vector machines: development of QSAR models for predicting anti-HIV-1 activity of TIBO derivatives.
    Darnag R; Mostapha Mazouz EL; Schmitzer A; Villemin D; Jarid A; Cherqaoui D
    Eur J Med Chem; 2010 Apr; 45(4):1590-7. PubMed ID: 20110136
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TIBO R82913, a new HIV-1 inhibiting agent, does not inhibit hematopoietic progenitor cells.
    Geissler RG; Ganser A; Ottmann OG; Kojouharoff G; Reutzel P; Andries K; Schellekens K; Hoelzer D
    AIDS Res Hum Retroviruses; 1991 Dec; 7(12):1021-3. PubMed ID: 1812943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. N-aminoimidazole derivatives inhibiting retroviral replication via a yet unidentified mode of action.
    Lagoja IM; Pannecouque C; Van Aerschot A; Witvrouw M; Debyser Z; Balzarini J; Herdewijn P; De Clercq E
    J Med Chem; 2003 Apr; 46(8):1546-53. PubMed ID: 12672256
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HIV inhibitors targeted at the reverse transcriptase.
    De Clercq E
    AIDS Res Hum Retroviruses; 1992 Feb; 8(2):119-34. PubMed ID: 1371690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pyridinone derivatives: specific human immunodeficiency virus type 1 reverse transcriptase inhibitors with antiviral activity.
    Goldman ME; Nunberg JH; O'Brien JA; Quintero JC; Schleif WA; Freund KF; Gaul SL; Saari WS; Wai JS; Hoffman JM
    Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6863-7. PubMed ID: 1713693
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new series of pyridinone derivatives as potent non-nucleoside human immunodeficiency virus type 1 specific reverse transcriptase inhibitors.
    Dollé V; Fan E; Nguyen CH; Aubertin AM; Kirn A; Andreola ML; Jamieson G; Tarrago-Litvak L; Bisagni E
    J Med Chem; 1995 Nov; 38(23):4679-86. PubMed ID: 7473595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-AIDS agents. 15. Synthesis and anti-HIV activity of dihydroseselins and related analogs.
    Huang L; Kashiwada Y; Cosentino LM; Fan S; Chen CH; McPhail AT; Fujioka T; Mihashi K; Lee KH
    J Med Chem; 1994 Nov; 37(23):3947-55. PubMed ID: 7525962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and structure-activity relationships of phenylenebis(methylene)-linked bis-tetraazamacrocycles that inhibit human immunodeficiency virus replication. 2. Effect of heteroaromatic linkers on the activity of bicyclams.
    Bridger GJ; Skerlj RT; Padmanabhan S; Martellucci SA; Henson GW; Abrams MJ; Joao HC; Witvrouw M; De Vreese K; Pauwels R; De Clercq E
    J Med Chem; 1996 Jan; 39(1):109-19. PubMed ID: 8568797
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Imidazo[1,5-b]pyridazine-d4T conjugates: synthesis and anti-human immunodeficiency virus evaluation.
    Renoud-Grappin M; Fossey C; Fontaine G; Ladurée D; Aubertin AM; Kirn A
    Antivir Chem Chemother; 1998 May; 9(3):205-23. PubMed ID: 9875400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predicting anti-HIV activity of TIBO derivatives: a computational approach using a novel topological descriptor.
    Sardana S; Madan AK
    J Mol Model; 2002 Aug; 8(8):258-65. PubMed ID: 12324803
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human immunodeficiency virus type 1 (HIV-1) strains selected for resistance against the HIV-1-specific [2',5'-bis-O-(tert-butyldimethylsilyl)-3'-spiro- 5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide)]-beta-D-pentofurano syl (TSAO) nucleoside analogues retain sensitivity to HIV-1-specific nonnucleoside inhibitors.
    Balzarini J; Karlsson A; Vandamme AM; Pérez-Pérez MJ; Zhang H; Vrang L; Oberg B; Bäckbro K; Unge T; San-Félix A
    Proc Natl Acad Sci U S A; 1993 Aug; 90(15):6952-6. PubMed ID: 7688467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-HIV-1 activity of antiviral compounds, as quantitated by a focal immunoassay in CD4+ HeLa cells and a plaque assay in MT-4 cells.
    Nakashima H; Balzarini J; Pauwels R; Schols D; Desmyter J; De Clercq E
    J Virol Methods; 1990 Aug; 29(2):197-208. PubMed ID: 1980126
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and study of anti-HIV-1 RT activity of 5-benzoyl-4-methyl-1,3,4,5-tetrahydro-2H-1,5-benzodiazepin-2-one derivatives.
    Chander S; Tang CR; Al-Maqtari HM; Jamalis J; Penta A; Hadda TB; Sirat HM; Zheng YT; Sankaranarayanan M
    Bioorg Chem; 2017 Jun; 72():74-79. PubMed ID: 28371664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and antiviral activities of 3-aralkylthiomethylimidazo[1,2-b]pyridazine derivatives.
    Galtier C; Mavel S; Snoeck R; Andreï G; Pannecouque C; Witvrouw M; Balzarini J; De Clercq E; Gueiffier A
    Antivir Chem Chemother; 2003 Jul; 14(4):177-82. PubMed ID: 14582846
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure-activity relationships of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine analogues: effect of substitutions at the C-6 phenyl ring and at the C-5 position on anti-HIV-1 activity.
    Tanaka H; Takashima H; Ubasawa M; Sekiya K; Nitta I; Baba M; Shigeta S; Walker RT; De Clercq E; Miyasaka T
    J Med Chem; 1992 Jan; 35(2):337-45. PubMed ID: 1732552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.